Document Detail

Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
MedLine Citation:
PMID:  16880311     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We evaluated the risk of gestational trophoblastic neoplasia (GTN) for women with partial molar pregnancy whose human chorionic gonadotropin (hCG) levels fall spontaneously to undetectable levels using a sensitive hCG assay. METHODS: We analyzed data from the New England Trophoblastic Disease Center to estimate the risk of GTN among 284 women with partial molar pregnancy and at least 6 months of gonadotropin follow-up. RESULTS: None of the 238 women with complete gonadotropin follow-up and a spontaneous decline in serum hCG levels to undetectable levels subsequently developed GTN (95% confidence interval 0-1.6%). CONCLUSION: If these results are replicated at other institutions with longstanding experience managing partial molar pregnancies, it may be reasonable to abbreviate clinical follow-up for women with partial molar pregnancy whose serum hCG levels spontaneously decline to an undetectable level.
Adam J Wolfberg; Whitfield B Growdon; Colleen M Feltmate; Donald P Goldstein; David R Genest; Manuel E Chinchilla; Ross S Berkowitz; Ellice S Lieberman
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  108     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-01     Completed Date:  2006-09-07     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  393-6     Citation Subset:  AIM; IM    
Department of Obstetrics, Gynecology, and Reproductive Biology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chorionic Gonadotropin / blood*
Hydatidiform Mole / blood*,  epidemiology,  etiology
Massachusetts / epidemiology
Medical Records
Neoplasm Recurrence, Local / blood*,  epidemiology,  etiology
Predictive Value of Tests
Retrospective Studies
Tumor Markers, Biological / blood*
Uterine Neoplasms / blood*,  epidemiology,  etiology
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A new approach to office hysteroscopy compared with traditional hysteroscopy: a randomized controlle...
Next Document:  Cervical cancer screening, abnormal cytology management, and counseling practices in the United Stat...